CTKB Net Income Growth
-1158.83%TTM
Period ending:
CTKB TTM Net Income YoY %%
210.22%-1305.52%
2021-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
CTKB net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 19 observations from Dec 31, 2021 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| -1,158.8346% | |
| -557.6875% | |
| -1,005.4826% | |
| -26.1935% | |
| 63.5395% | |
| 2.2415% | |
| 50.4527% | |
| 28.0626% | |
| -192.6% | |
| -420.8145% | |
| -571.5839% | |
| -558.6754% | |
| -151.046% | |
| -351.7084% | |
| -14.1619% | |
| -121.8977% | |
| -116.0284% | |
| -95.6859% | |
| -84.5397% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All CTKB financial metrics · CTKB stock overview · How to interpret financial metrics
